New cholesterol-lowering drugs anticipated release in six months

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

ST. LOUIS, MO (KTVI) - Cholesterol drugs are among the most prescribed in America. A new class of cholesterol drugs could be a game-changer.

Dr. Justin Sadhu, a cardiologist at Barnes-Jewish Hospital, shares his thoughts on the newest cholesterol-lowering drugs.

Similar to the way insulin is given to those with Diabetes, Alirocumab or Evolocumab the cholesterol drugs are given as injections. The patient would receive these injections either once every two weeks or once every four weeks.

The drugs have received an FDA advisory approval. An advisory committee recommended the FDA to approve these drugs and Dr. Sadhu anticipates the drugs to be available within the next six months.

If you would like to learn more about managing high cholesterol visit Barnes-Jewish Hospital’s website.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.